These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
337 related articles for article (PubMed ID: 10085992)
1. New pediatric dosage rules: information and testing. Feeg VD Pediatr Nurs; 1998; 24(6):518, 613. PubMed ID: 10085992 [No Abstract] [Full Text] [Related]
2. Improving pediatric dosing through pediatric initiatives: what we have learned. Rodriguez W; Selen A; Avant D; Chaurasia C; Crescenzi T; Gieser G; Di Giacinto J; Huang SM; Lee P; Mathis L; Murphy D; Murphy S; Roberts R; Sachs HC; Suarez S; Tandon V; Uppoor RS Pediatrics; 2008 Mar; 121(3):530-9. PubMed ID: 18310202 [TBL] [Abstract][Full Text] [Related]
3. Therapeutic orphans: who speaks for children? Shirkey HC South Med J; 1970 Nov; 63(11):1361-3. PubMed ID: 5475304 [No Abstract] [Full Text] [Related]
4. Off-label or off-limits? Ritchey ML J Urol; 2013 Jul; 190(1):8-9. PubMed ID: 23608037 [No Abstract] [Full Text] [Related]
5. FDA labeling status of pediatric medications. Yoon EY; Davis MM; El-Essawi H; Cabana MD Clin Pediatr (Phila); 2006; 45(1):75-7. PubMed ID: 16429220 [No Abstract] [Full Text] [Related]
6. Characteristics of container labeling in a sample of commonly prescribed children's oral medications. Wallace LS; Keenum AJ; DeVoe JE Res Social Adm Pharm; 2010 Dec; 6(4):272-9. PubMed ID: 21111385 [TBL] [Abstract][Full Text] [Related]
7. Regulations requiring manufacturers to assess the safety and effectiveness of new drugs and biological products in pediatric patients--FDA. Final rule. Fed Regist; 1998 Dec; 63(231):66631-72. PubMed ID: 10338880 [TBL] [Abstract][Full Text] [Related]
8. The Food and Drug Administration's paternalism. Somberg JC Am J Ther; 2010; 17(6):533-4. PubMed ID: 21060255 [No Abstract] [Full Text] [Related]
10. Pediatric drug studies. Protecting pint-sized patients. Nordenberg T FDA Consum; 1999; 33(3):23-8. PubMed ID: 10443186 [No Abstract] [Full Text] [Related]
11. American Academy of Pediatrics. Committee on drugs. Drug testing in children: FDA regulations. Pediatrics; 1969 Mar; 43(3):463-5. PubMed ID: 5818481 [No Abstract] [Full Text] [Related]
12. FDA problems with medications in the marketplace: III. 'Therapeutic orphans'. Archambault GF Hosp Formul; 1976 Dec; 11(12):690. PubMed ID: 1028797 [No Abstract] [Full Text] [Related]
13. New FDA rules force drug makers to detail youth-specific effects. Food and Drug Administration. Newsline People AIDS Coalit N Y; 1999 Jan; ():34. PubMed ID: 11367188 [TBL] [Abstract][Full Text] [Related]
14. The federal preemption debate in pharmaceutical labeling product liability actions. Gross JM; Curry JA Tort Trial Insur Pract Law J; 2007; 43(1):35-70. PubMed ID: 18354866 [No Abstract] [Full Text] [Related]
15. The new FDA pregnancy labeling requirements for drugs. Frederiksen MC J Midwifery Womens Health; 2011; 56(3):303-7. PubMed ID: 21535377 [TBL] [Abstract][Full Text] [Related]
16. Deterring the importation of counterfeit pharmaceutical products. Stearn DW Food Drug Law J; 2004; 59(4):537-61. PubMed ID: 15875351 [No Abstract] [Full Text] [Related]
17. Drug reactions: the role of the package insert. Barnett FJ J Leg Med (N Y); 1973; 1(1):19-23. PubMed ID: 4548069 [No Abstract] [Full Text] [Related]
18. FDA proposes more stringent pediatric-use labeling of prescription drug products. Am J Hosp Pharm; 1993 Jan; 50(1):13, 16. PubMed ID: 8427271 [No Abstract] [Full Text] [Related]
19. Drugs and biologics in pregnancy and breastfeeding: FDA in the 21st century. Kweder SL Birth Defects Res A Clin Mol Teratol; 2008 Sep; 82(9):605-9. PubMed ID: 18704917 [No Abstract] [Full Text] [Related]
20. Pediatric efficacy supplement for Videx EC. AIDS Patient Care STDS; 2008 Nov; 22(11):919. PubMed ID: 19043843 [No Abstract] [Full Text] [Related] [Next] [New Search]